Wikidata

(Q66406368)

English

Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

clinical trial

In more languages

Statements

title
A Pilot and Phase II Study to Assess the Safety, Tolerability and Efficacy of Pembrolizumab Plus Chemotherapy in Metastatic Triple Negative Breast Cancer Patients (English)
0 references
start time
23 February 2016
0 references
end time
May 2021
0 references
number of participants
88
0 references
research intervention
paclitaxel
0 references
pembrolizumab
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66406368&oldid=1858909269"